Northwest Biotherapeutics | NWBO - Passivo Circulante





Passivo Circulante Alterar Data
Agenus USD 231.82M 17.42M 2026-06
AstraZeneca USD 31.55B 1.02B 2026-06
Bristol-Myers Squibb USD 18.66B 499M 2026-06
Celldex Therapeutics USD 61.32M 9.85M 2026-06
Eisai JPY 393.64B 53.39B 2026-06
Merck USD 27.73B 786M 2026-06
Northwest Biotherapeutics USD 82.97M 4.93M 2026-03
Pfizer USD 32.65B 1.7B 2026-06
Plus Therapeutics USD 8.57M 612K 2026-06
Roche Holding CHF 28.85B 846M 2026-06